An interventional study of Minimal Fresh Gas Flow at 0.3 L/min and Fresh Gas Flow at 2 L/min in Respiratory Mechanics, Carbon Footprint and Low-Flow Anesthesia, sponsored by Hande Gurbuz. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.
Sponsored by Hande Gurbuz · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 144 studies in Postoperative Complications with a site in Turkey — 33 open to participants now, 40 under way, none of them phase 3. Postoperative Complications · Turkey.
Among the 144 studies in Postoperative Complications with a site in Turkey, this one is the 30th largest by planned enrollment of the 67 interventional ones that give a count, is one of 21 that started in 2026, is one of 59 with no phase, reaches primary completion later than 37 of the 39 other live ones, and was the 144th registered.
1,338 studies on the registry are indexed under Postoperative Complications; 311 are open to participants now.
Browse Postoperative Complications studies →33 of the 144 studies in Postoperative Complications with a site in Turkey are open now. Recruiting first, the newest first:
Marmara University · Sites in Turkey
Ages 18–75
Van Training and Research Hospital · Sites in Turkey
Ages 60+
Ankara University · Sites in Turkey
Ages 18+ · Men only
Antalya City Hospital · Sites in Turkey
Ages 18–80 · Women only
Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital · Sites in Turkey, Italy
Ages 18+
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 201 Postoperative Complications studies recruiting now, 126 (63%) set no upper age limit and 32 (16%) stop at 75 or younger; 24 take children under 18; 25 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
144 studies; the count open now beside each. This study's row is marked.
First in 2011; this study’s year is marked. 21 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 86 is below the median of 114 across 770 interventional studies indexed under Postoperative Complications.
Median enrollment 80 across the 67 interventional studies, 145 across the 77 observational. Of the 93 that completed or were terminated, 3 (3%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 144 has an industry lead sponsor. The 10 most frequent:
Hande Gurbuz is the lead sponsor of 3 studies on the registry; 2 are open to participants now.
Hande Gurbuz has 1 study filed under Postoperative Complications — fewer than ten, so there is no comparison to draw.
8 of the studies in Postoperative Complications with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07800767Koşuyolu Kartal Heart Training and Research HospitalAnesthesia Management, Inflammatory Response and Recovery After Non-intubated VATS Pericardial Window | 2026-11-30 |
| NCT07800845Konya City HospitalRemifentanil vs Fentanyl in Children 7-12 After Urologic Surgery: Emergence Delirium and Recovery Quality | 2026-12-15 |
| NCT07729319Marmara UniversityClinical Effects of Intraoperative Heat and Moisture Exchange Systems During Thoracic Surgery: A Prospective Observational Cohort Study | 2027-04 |
| NCT07751692Fatih Sultan Mehmet Training and Research HospitalGNRI and Rectus Femoris Muscle Thickness in Older Patients Undergoing Hip Fracture Surgery | 2027-05 |
| NCT07815392Van Training and Research HospitalPreoperative Frailty and Postoperative Outcomes in Older Patients Undergoing Surgery for Gastrointestinal Cancer | 2027-06-01 |
Add all 8 to your calendar (.ics) → With an account.
Among the 144 studies in Postoperative Complications with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study will compare two fresh gas flow rates during general anesthesia in adults undergoing lumbar stabilization surgery while lying face down. Fresh gas flow is the rate at which oxygen and other gases are supplied to the anesthesia breathing system. Lower flow rates may reduce anesthetic use and its environmental impact, but their effects on breathing during prolonged surgery need further evaluation.
Seventy adults will be randomly assigned to receive a fresh gas flow rate of either 0.3 or 2 liters per minute. Both groups will receive sevoflurane anesthesia and standardized mechanical ventilation.
The main outcome is the percentage change in dynamic respiratory system compliance, a measure of how easily the lungs and chest expand during ventilation, between 10 and 120 minutes after reaching the assigned flow rate. Other assessments will include breathing mechanics, blood oxygen and carbon dioxide levels, brain oxygenation, lung ultrasound findings, postoperative oxygen needs, pulmonary complications, and hospital length of stay. Anesthetic and fresh gas consumption, anesthetic cost, and estimated greenhouse gas emissions will also be compared. Fresh gas flow will be increased if predefined safety criteria are met.
This single-center trial will be conducted at Bursa City Hospital. Adults aged 18 years or older who are scheduled for elective lumbar stabilization surgery in the prone position will be enrolled. Eligible participants will have an American Society of Anesthesiologists physical status classification of I-III, a body mass index below 40 kg/m², and no known pulmonary disease. Written informed consent will be obtained before enrollment. Participants will be assigned by computer-generated randomization to two parallel groups: minimal fresh gas flow at 0.3 L/min or comparator fresh gas flow at 2 L/min.
Before anesthesia induction, demographic characteristics, comorbidities, smoking status, and hemoglobin levels will be recorded. Lung ultrasound will assess 12 zones, with each zone scored from 0 to 3, yielding a total score of 0-36. Higher scores indicate greater loss of lung aeration.
Automated controlled anesthesia will be used to target an end-tidal sevoflurane concentration corresponding to approximately 1 minimum alveolar concentration, with a bispectral index target of 40-60. Volume-controlled ventilation will be standardized.
High fresh gas flow will initially be used after induction and tracheal intubation. After prone positioning and confirmation of hemodynamic and ventilatory stability, the assigned fresh gas flow rate will be applied. Measurements will be obtained at the following time points:
T1: 5-10 minutes after intubation, while supine during the initial high-flow period.
T2: 10 minutes after reaching the assigned fresh gas flow rate in the prone position.
T3: 30 minutes after reaching the assigned flow rate. T4: 60 minutes after reaching the assigned flow rate. T5: 120 minutes after reaching the assigned flow rate.
Respiratory mechanics, hemodynamic variables, cerebral oxygenation, and arterial blood gas measurements will be recorded at the specified intraoperative time points. Dynamic compliance will be calculated as expired tidal volume divided by the difference between peak inspiratory pressure and positive end-expiratory pressure. Its percentage change will be calculated as [(T5 value - T2 value) / T2 value] × 100. Plateau pressure will be measured using an inspiratory hold. Static compliance, driving pressure, airway resistance, elastance, and mechanical power will also be evaluated. Pulmonary gas exchange assessments will include the PaO2/FiO2 ratio, the alveolar-arterial oxygen gradient, and the arterial-to-end-tidal carbon dioxide difference.
At 30 minutes after surgery in the postanesthesia care unit, lung ultrasound, peripheral oxygen saturation, supplemental oxygen requirements, pain, and early pulmonary complications will be assessed. The change in lung ultrasound score will be calculated as the postoperative score minus the preoperative score. Pulmonary complications during hospitalization and hospital length of stay will also be recorded.
Total sevoflurane and fresh gas consumption will be obtained from the anesthesia workstation. Sevoflurane cost will be calculated using the consumed volume and the unit price determined at the end of the study. Estimated sevoflurane-related carbon dioxide equivalent emissions will be calculated using the protocol-specified conversion factor of approximately 0.198 kg CO2e per milliliter of sevoflurane.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will receive a fresh gas flow rate of 0.3 L/min during sevoflurane anesthesia after prone positioning and confirmation of hemodynamic and ventilatory stability. Mechanical ventilation will follow the standardized study protocol. High fresh gas flow will be used if predefined rescue criteria are met.
Other: Minimal Fresh Gas Flow at 0.3 L/min
Participants will receive a fresh gas flow rate of 2 L/min during sevoflurane anesthesia after prone positioning and confirmation of hemodynamic and ventilatory stability. Mechanical ventilation will follow the standardized study protocol. High fresh gas flow will be used if predefined rescue criteria are met.
Other: Fresh Gas Flow at 2 L/min
Fresh gas flow will be reduced to 0.3 L/min after prone positioning and confirmation of hemodynamic and ventilatory stability. Sevoflurane will be administered using automated controlled anesthesia to target approximately 1 minimum alveolar concentration. The assigned flow will be maintained unless predefined rescue criteria require an increase in fresh gas flow.
Fresh gas flow will be set at 2 L/min after prone positioning and confirmation of hemodynamic and ventilatory stability. Sevoflurane will be administered using automated controlled anesthesia to target approximately 1 minimum alveolar concentration. The assigned flow will be maintained unless predefined rescue criteria require an increase in fresh gas flow.
Percentage Change in Dynamic Respiratory System Compliance
Dynamic respiratory system compliance (Cdyn), expressed in mL/cmH2O, will be recorded directly from the anesthesia workstation. The percentage change will be calculated as \[(Cdyn at T5 - Cdyn at T2) / Cdyn at T2\] × 100. T2 is 10 minutes and T5 is 120 minutes after reaching the assigned fresh gas flow rate in the prone position. Negative values indicate a decrease in compliance; higher values indicate better preservation of compliance.
Time frame: From 10 to 120 minutes after reaching the assigned fresh gas flow rate in the prone position during surgery.
Change in Static Respiratory System Compliance
Static respiratory system compliance (Cstat) will be calculated as expired tidal volume divided by plateau pressure minus positive end-expiratory pressure and expressed in mL/cmH2O. Plateau pressure will be measured during a 2-second inspiratory hold. The change will be calculated as Cstat at T5 minus Cstat at T2. Negative values indicate a decrease in compliance.
Time frame: From 10 to 120 minutes after reaching the assigned fresh gas flow rate in the prone position during surgery.
Change in Driving Pressure
Driving pressure will be calculated as plateau pressure minus positive end-expiratory pressure and expressed in cmH2O. Plateau pressure will be measured during a 2-second inspiratory hold. The change will be calculated as driving pressure at T5 minus driving pressure at T2. Positive values indicate an increase in driving pressure.
Time frame: From 10 to 120 minutes after reaching the assigned fresh gas flow rate in the prone position during surgery.
Change in Airway Resistance
Airway resistance will be recorded directly from the anesthesia workstation and expressed in cmH2O·s/L. The change will be calculated as airway resistance at T5 minus airway resistance at T2. Positive values indicate an increase in airway resistance.
Time frame: From 10 to 120 minutes after reaching the assigned fresh gas flow rate in the prone position during surgery.
Change in Mechanical Power
Mechanical power during volume-controlled ventilation will be calculated as: 0.098 × tidal volume (L) × respiratory rate (breaths/min) × \[peak inspiratory pressure - 0.5 × (plateau pressure - positive end-expiratory pressure)\]. Pressures will be expressed in cmH2O and mechanical power in J/min. The change will be calculated as mechanical power at T5 minus mechanical power at T2. Positive values indicate an increase in mechanical power.
Time frame: From 10 to 120 minutes after reaching the assigned fresh gas flow rate in the prone position during surgery.
Change in Respiratory System Elastance
Respiratory system elastance will be recorded directly from the anesthesia workstation. The change will be calculated as elastance at T5 minus elastance at T2. Positive values indicate increased respiratory system stiffness.
Time frame: From 10 to 120 minutes after reaching the assigned fresh gas flow rate in the prone position during surgery.
Change in PaO2/FiO2 Ratio
The PaO2/FiO2 ratio will be calculated by dividing arterial oxygen partial pressure (PaO2, in mmHg) by the simultaneously recorded inspired oxygen fraction (FiO2, expressed as a decimal). The change will be calculated as the ratio at T5 minus the ratio at T2 and expressed in mmHg. Positive values indicate improved oxygenation.
Time frame: From 10 to 120 minutes after reaching the assigned fresh gas flow rate in the prone position during surgery.
Total Sevoflurane Consumption
Total liquid sevoflurane consumption during anesthesia will be recorded directly from the anesthesia workstation and expressed in milliliters.
Time frame: From the start of anesthesia to the end of anesthesia on the day of surgery.
Estimated Sevoflurane-Related Carbon Dioxide Equivalent Emissions
Estimated carbon dioxide equivalent (CO2e) emissions associated with sevoflurane consumption will be calculated by multiplying the total liquid sevoflurane volume consumed during anesthesia by the protocol-specified conversion factor of 0.198 kg CO2e per milliliter. Results will be expressed in kilograms of CO2e. This estimate covers sevoflurane-related emissions rather than the total carbon footprint of anesthesia or surgery.
Time frame: From the start of anesthesia to the end of anesthesia on the day of surgery.
Change in Lung Ultrasound Score
Lung aeration will be assessed using a 12-zone lung ultrasound examination. Each zone will be scored from 0 to 3, yielding a total score of 0-36, with higher scores indicating greater loss of aeration. The change will be calculated as the postoperative score minus the preoperative score. Positive values indicate worsening lung aeration.
Time frame: From before anesthesia induction to 30 minutes after surgery in the postanesthesia care unit.
Incidence of Postoperative Pulmonary Complications
The proportion of participants experiencing at least one postoperative pulmonary complication during hospitalization will be compared between groups. Complications will include atelectasis, pneumonia, respiratory failure, bronchospasm, aspiration pneumonitis, pleural effusion, and pneumothorax. Each participant will be counted once for the overall incidence, regardless of the number of complications. The type of each complication will also be recorded.
Time frame: Postoperative hospitalization, an average of 10 days.
Plan to share: No — There is no plan to share individual participant data with other researchers. Study findings will be reported in aggregate form.
Start is estimated for Nov 2026; primary completion for Dec 2027, 13 months later.
Of 395 non-industry interventional studies with no phase under Postoperative Complications, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 44. This study's planned 13 months is below that.
Counting every sponsor, half of 399 studies reached it within 20 months; a quarter within 8 and three quarters within 44.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.